New drug combination before surgery may improve outcomes in breast cancer patients

[News]

Results from the I-SPY 2 trial show that giving patients with HER2-positive invasive breast cancer a combination of the drugs trastuzumab emtansine (T-DM1) and pertuzumab before surgery was more beneficial than the combination of paclitaxel plus trastuzumab.

More... (http://www.news-medical.net/news/20160419/New-drug-combination-before-surgery-may-improve-outcomes-in-breast-cancer-patients.aspx)